Just In
- 2 hrs ago Daily Horoscope, 24 April 2024: Scorpions May Recieve Good News In The Second Half The Day
- 13 hrs ago Anant Ambani-Radhika Merchant's Wedding Function Details Are Out, Check out Ambani Bahu-To-Be's Chic Fashion!
- 13 hrs ago Nayanthara Poses With Husband Vignesh Shivan In Chic Saree, Check Her Sarees To Ace Summer Wedding Look
- 17 hrs ago Hanuman Jayanti 2024: These Are Lord Hanuman's Favourite Zodiac Signs, Check Out The List!
Don't Miss
- Sports Most Sixes in IPL Since 2022: Shivam Dube Back on Top in The Big-Hitting Charts After CSK vs LSG in IPL 2024
- Movies Aavesham Box Office Collection Day 14 Prediction: Fahadh Faasil's Film Shows Steady Performance
- Finance IRCTC vs Cochin Shipyard: Which PSU Stock Has Higher Upside Potential? Sumeet Bagadia Answers
- Technology Apple Confirms Special Event for May 7: iPad Air, iPad Pro 2024 Models Expected
- News Senator Lambie Calls For Elon Musk's Imprisonment Over Wakeley Church Stabbing Posts
- Education Telangana Inter Manabadi 1st and 2nd Year Results 2024 to be Declared Tomorrow
- Automobiles Chrysler Pacifica Marks Seven Years As Most Awarded Minivan With New Campaign
- Travel Kurnool's Hidden Gems: A Guide To Exploring India's Lesser-Known Treasures
Masked Cancer Drug Stealthily Trains Immune System To Kill Tumours While Sparing Healthy Tissues
Many cancer treatments are notoriously savage on the body. Drugs often attack both healthy cells and tumour cells, causing a plethora of side effects. Immunotherapies that help the immune system recognise and attack cancer cells are no different.
Though they have prolonged the lives of countless patients, they work with only a subset of patients. One study found that fewer than 30% of breast cancer patients respond to one of the most common forms of immunotherapy.
But what if drugs could be engineered to attack only tumour cells and spare the rest of the body? To that end, my colleagues and I at the University of Chicago's Pritzker School of Molecular Engineering have designed a method to keep one promising cancer drug from wreaking havoc by "masking" it until it reaches a tumour. Immunotherapies help the immune system recognise and target cancer cells.
The Promise of IL-12
Cytokines are proteins that can modulate how the immune system responds to threats. One way they do this is by activating killer T cells, a type of white blood cell that can attack cancer cells. Because cytokines can train the immune system to kill tumours, this makes them very promising as cancer treatments.
One such cytokine is interleukin-12 or IL-12. Though it was discovered more than 30 years ago, IL-12 still isn't an FDA-approved therapy for cancer patients because of its severe side effects, such as liver damage. This is in part because IL-12 instructs immune cells to produce a large amount of inflammatory molecules that can damage the body.
Scientists have since been working to reengineer IL-12 to be more tolerable while retaining its powerful cancer-killing effects.
Masking the killer
To create a safer version of IL-12, my colleagues and I took advantage of one of the main differences between healthy and cancerous tissue: an excess of growth-promoting enzymes in cancers. Because cancer cells proliferate very rapidly, they overproduce certain enzymes that help them invade the nearby healthy tissue and metastasize to other parts of the body. Healthy cells grow at a much slower pace and produce fewer of these enzymes.
With this in mind, we "masked" IL-12 with a cap that covers the part of the molecule that normally binds to immune cells to activate them. The cap is removed only when it comes into contact with enzymes found in the vicinity of tumours. When these enzymes chop off the cap, IL-12 is reactivated and spurs nearby killer T cells to attack the tumour.
Killer T cells surrounding a cancer cell
Killer T cells (green and red) can attach to cancer cells (blue, centre) and kill them by releasing toxic chemicals (red), a move scientists have dubbed 'the kiss of death.'
When we applied these masked IL-12 molecules to both healthy and tumour tissue donated by melanoma and breast cancer patients, our results confirmed that only the tumour samples were able to remove the cap. This indicated that masked IL-12 could potentially drive a strong immune response against tumours without causing damage to healthy organs.
We then examined how safe masked IL-12 is by measuring liver damage biomarkers in mice. We found that immune-related side effects typically associated with IL-12 were notably absent in mice treated with masked IL-12 over a period of several weeks, indicating improved safety.
In breast cancer models, our masked IL-12 resulted in a 90% cure rate, while treatment with a commonly used immunotherapy called a checkpoint inhibitor resulted in only a 10% cure rate. In a model of colon cancer, masked IL-12 showed a 100% cure rate.
Our next step is to test the modified IL-12 in cancer patients. While it will take time to bring this encouraging development directly to patients, we believe a promising new treatment is on the horizon.
Inputs from The Conversation.
- healthExclusive: Cervical Cancer In India, Doctor Shares Preacautions And Treatments That One Needs To Be Aware Of
- healthTV Actor Dolly Sohi Passes Away Due To Cervical Cancer, Know The Early Signs That Are Beyond Early Detection
- healthGhazal Maestro Pankaj Udhas Passes Away Due To Pancreatic Cancer, Know Risk Factors, Prevention, Treatments
- healthNew Study Finds Links Infertility In Men With Increased Risk Of Cancer For Them And Their Relatives
- healthIs Pancreatic Cancer Curable? Know The Causes, Warning Signs, And Treatment Of This Uncommon Silent Killer
- insyncBaba Vanga's Prophecy For 2024 May Come True With New Vaccine In Russia For Cancer
- healthDetecting Bowel Cancer: 10 Signs Of This Silent Killer To Watch Out For And Seek Medical Attention
- health10 Cancer Fighting Foods That Help That Play Significant Role In Supporting Body's Natural Defences
- healthWorld Cancer Day 2024: 5 Simple Daily Habits To Reduce The Risk Of Developing Cancer
- healthWorld Cancer Day 2024: Messages, Greetings, Wishes, Texts, Images, FB And WhatsApp Status
- healthExclusive: Poonam Pandey Didn't Die Of Cancer, However, It Does Spark Urgency For Cervical Cancer Awareness
- healthErotica Star Poonam Pandey 'Dead From Cervical Cancer' Stunt: Causes, Symptoms, Treatment Of Cervical Cancer